Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study is designed to evaluate the potential for a pharmacokinetic (PK) drug-drug interaction between IDX320 and IDX184 and to assess the safety and tolerability when the two drugs are administered in combination in healthy participants.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
To participate in the study, participants must meet the following requirements:
Exclusion criteria
Participants are not eligible if they meet any of the following:
Primary purpose
Allocation
Interventional model
Masking
20 participants in 3 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal